Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PDGF Rb | cis | Discovery | rs11746309 | 5:149,479,647 | G/A | 0.28 | 997 | -0.379 | 0.050 | 1.2×10-13 | -1.180 | 3.1×10-12 | 0.005 |
PDGF Rb | cis | Replication | rs4337842 | 5:149,479,852 | C/A | 0.31 | 337 | 0.044 | 0.072 | 0.543 | 1.020 | 0.612 | 0.41 |
Target (abbrv.) | PDGF Rb |
Target (full name) | Platelet-derived growth factor receptor beta |
Somalogic ID (Sequence ID) | SL004155 (3459-49_2) |
Entrez Gene Symbol | PDGFRB |
UniProt ID | P09619 |
UniProt Comment |
|
Targeted by drugs (based on IPA annotation) |
|
Biomarker applications (based on IPA annotation) |
|
Wiki Pathways |
|
Pathway Interaction Database |
|
Reactome |
|
Pathway Studio |
|
All locus annotations are based on the sentinel SNP (rs11746309) and 5 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by | |
eQTL genes |
Trait | P | Study | Source |
---|---|---|---|
cg16492211 (chr5:149487220) | 3.3×10-7 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
Alzheimer's disease (APOE4/E3 heterozygotes) | 2.6×10-4 | 21379329 (PMID) | GRASP2 nonQTL |